WO2017042567A1 - Use of cannabinoids in the treatment of mental ...,https://www.google.com/patents/WO2017042567A1?cl=no
Glutamate agents in the treatment of mental disorders - Google ...,https://www.google.com/patents/US20140249173
WO2005046434A8 - Compositions and methods for diagnosing and ...,https://www.google.com/patents/WO2005046434A8?cl=un
EP3085366A1 - Nmda antagonists for the treatment of mental ...,https://www.google.com/patents/EP3085366A1?cl=pt
EP2800581A1 - Methods of treating behavioral symptoms of ...,https://www.google.com/patents/EP2800581A1?cl=es
US20130211183A1 - Methods for Treating Psychiatric Disorders ...,https://www.google.com/patents/US20130211183
EP2570493B1 - Genetic markers of mental illness - Google Patents,http://www.google.com/patents/EP2570493B1
WO2014138987A1 - Use of electroretinography (erg) for the ...,https://www.google.com/patents/WO2014138987A1?cl=da
WO1998046128A1 - Method for diagnosing psychiatric disorders ...,https://www.google.com/patents/WO1998046128A1?cl=en
Compositions and methods for diagnosing and treating mental ...,http://www.google.com/patents/US20110224144
